Conditional relative survival among patients with follicular lymphoma: a population-based study in the Netherlands-Reference-Cited by-同舟云学术

Conditional relative survival among patients with follicular lymphoma: a population-based study in the Netherlands

Published:2021-01 Issue:1 Volume:11 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Dinnessen Manette A. W.^ORCID,Visser Otto,Tonino Sanne H.,Posthuma Eduardus F. M.,Blijlevens Nicole M. A.,Kersten Marie José,Lugtenburg Pieternella J.,Dinmohamed Avinash G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-020-00399-8.pdf

Reference17 articles.

1. Junlen, H. R. et al. Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study. Leukemia 29, 668–676 (2015).

2. Sant, M. et al. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. 15, 931–942 (2014).

3. van de Schans, S. A. M., van Steenbergen, L. N., Coebergh, J. W. W., Janssen-Heijnen, M. L. G. & van Spronsen, D. J. Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands. Haematologica 99, 339–345 (2014).

4. Migdady, Y., Salhab, M., Dang, N. H., Markham, M. J. & Olszewski, A. J. Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis. Leuk. Lymphoma 57, 676–684 (2016).

5. Schouten, L. J., Hoppener, P., van den Brandt, P. A., Knottnerus, J. A. & Jager, J. J. Completeness of cancer registration in Limburg, The Netherlands. Int. J. Epidemiol. 22, 369–376 (1993).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era;Leukemia;2022-03-04